Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

6(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Detailed Status

Completed4

Recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 16 (100.0%)

Trials by Status

recruiting117%

completed467%

not_yet_recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

not_yet_recruitingphase_1

Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects

NCT07540494

recruitingphase_1

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

NCT06511947

completedphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT07540494Phase 1

Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects

Not Yet Recruiting

NCT06511947Phase 1

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

Recruiting

NCT05753956Phase 1

Safety and Pharmacokinetics of GH002 in Healthy Volunteers

Completed

NCT04698603Phase 1

Clinical Study of GH001 in Depression

Completed

NCT04640831Phase 1

Safety of GH001 in Healthy Volunteers

Completed

NCT05163691Phase 1

Pharmacokinetics of GH001 in Healthy Volunteers

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6